Pacific Biosciences Of California (PACB) Cash & Equivalents (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Cash & Equivalents of $56.3 million for Q1 2026, down 3.82% year-over-year from $58.5 million in Q1 2025, and down 11.67% quarter-over-quarter from $63.7 million in Q4 2025.
Pacific Biosciences Of California (PACB) Cash & Equivalents (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $56.3 million for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 3.82% year-over-year to $56.3 million; the TTM figure through Mar 2026 stood at $56.3 million (down 3.82% YoY), while the FY2025 annual figure was $63.7 million, up 2767.1% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $56.3 million, down from $63.7 million in the prior quarter.
- The five-year high for Cash & Equivalents was $353.8 million in Q1 2023, with the low at $1.8 million in Q3 2025.
- The 5-year median for Cash & Equivalents is $5.5 million (2022), against an average of $76.7 million.
- The sharpest annual moves came in 2022 and 2023: Cash & Equivalents surged 9307.42% in 2022, then sank 99.12% in 2023.
- Pacific Biosciences Of California's Cash & Equivalents stood at $3.2 million in 2022, then decreased by 15.52% to $2.7 million in 2023, then dropped by 18.37% to $2.2 million in 2024, then soared by 2767.1% to $63.7 million in 2025, then fell by 11.67% to $56.3 million in 2026.
- Business Quant data shows PACB's Cash & Equivalents at $56.3 million in Q1 2026, $63.7 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn | 61.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.00 Mn |
| Mar 31, 2026 | 56.27 Mn |
| Dec 31, 2025 | 63.71 Mn |
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 54.80 Mn |
| Mar 31, 2025 | 58.51 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | 2.22 Mn |
| Jun 30, 2024 | 2.26 Mn |
| Mar 31, 2024 | 76.65 Mn |
| Dec 31, 2023 | 2.72 Mn |
| Sep 30, 2023 | 2.72 Mn |
| Jun 30, 2023 | 2.72 Mn |
| Mar 31, 2023 | 353.83 Mn |
| Dec 31, 2022 | 3.22 Mn |
| Sep 30, 2022 | 304.43 Mn |
| Jun 30, 2022 | 310.45 Mn |
| Mar 31, 2022 | 5.48 Mn |
| Dec 31, 2021 | 5.09 Mn |
| Jun 30, 2021 | 3.30 Mn |